Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022)

Pulse Biosciences' (PLSE) quarterly Asset Writedowns and Impairment came in at $1.1 million in Q4 2022.

Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022) Analysis & Trends

Pulse Biosciences' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	126.59 Bn	121.37 Bn	1.96 Bn
2	Becton Dickinson	44.89 Bn	44.07 Bn	2.15 Bn
3	Alcon	32.93 Bn	31.27 Bn	1.53 Bn
4	Medline	32.81 Bn	30.58 Bn	1.84 Bn
5	Resmed	29.39 Bn	27.73 Bn	890.98 Mn
6	West Pharmaceutical Services	23.40 Bn	22.97 Bn	329.20 Mn
7	Solventum	14.07 Bn	13.51 Bn	1.10 Bn
8	Cooper Companies	13.78 Bn	13.64 Bn	735.40 Mn
9	Align Technology	12.04 Bn	10.98 Bn	736.59 Mn
10	Pulse Biosciences	2.23 Bn	2.15 Bn	-

Download Data

Date	Value
Dec 31, 2022	1.11 Mn
Dec 31, 2022	1.11 Mn